Unknown PHASE2 INTERVENTIONAL 2-arm NCT01168505

Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients

The Role of Intravenous Iron to Prevent Anemia in Women With Breast Cancer Receiving (Neo)Adjuvant Chemotherapy

Sponsor: Fundação Faculdade de Medicina

Interventions ferric hydroxide saccharate

Updated 5 times since 2017 Last updated: May 20, 2014 Started: May 31, 2010 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01168505, this PHASE2 trial focuses on Breast Cancer and remains ongoing. Sponsored by Fundação Faculdade de Medicina, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundação Faculdade de Medicina
Instituto do Cancer do Estado de São Paulo

Data source: Instituto do Cancer do Estado de São Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil